Pharmaceutical

The Antihemophilic Factor Drug market was valued at US$ xx in 2021, prior to COVID-19. Whereas post-COVID-19 scenario, the market for Antihemophilic Factor Drug is projected to grow from US$ xx million in 2021, an…

• SKU :

  SAC2053507
• Published Date :

  June 1, 2022
• Number of Pages :

  350.0

The Acute Myeloid Leukemia Drugs market was valued at US$ xx in 2021, prior to COVID-19. Whereas post-COVID-19 scenario, the market for Acute Myeloid Leukemia Drugs is projected to grow from US$ xx million in 2021…

• SKU :

  SAC2053480
• Published Date :

  June 1, 2022
• Number of Pages :

  350.0

The Whey Protein Ingredient market was valued at US$ xx in 2021, prior to COVID-19. Whereas post-COVID-19 scenario, the market for Whey Protein Ingredient is projected to grow from US$ xx million in 2021, and is p…

• SKU :

  SAC2053408
• Published Date :

  June 1, 2022
• Number of Pages :

  350.0

The Benzonatate Capsules market was valued at US$ xx in 2021, prior to COVID-19. Whereas post-COVID-19 scenario, the market for Benzonatate Capsules is projected to grow from US$ xx million in 2021, and is project…

• SKU :

  SAC2053352
• Published Date :

  June 1, 2022
• Number of Pages :

  350.0

The Animal Free Soft Gelatin Capsules market was valued at US$ xx in 2021, prior to COVID-19. Whereas post-COVID-19 scenario, the market for Animal Free Soft Gelatin Capsules is projected to grow from US$ xx milli…

• SKU :

  SAC2053302
• Published Date :

  June 1, 2022
• Number of Pages :

  350.0

The Double Barreled Antibodies Drug market was valued at US$ xx in 2021, prior to COVID-19. Whereas post-COVID-19 scenario, the market for Double Barreled Antibodies Drug is projected to grow from US$ xx million i…

• SKU :

  SAC2052408
• Published Date :

  May 1, 2022
• Number of Pages :

  350.0

The Clavulanate Potassium market was valued at US$ xx in 2021, prior to COVID-19. Whereas post-COVID-19 scenario, the market for Clavulanate Potassium is projected to grow from US$ xx million in 2021, and is proje…

• SKU :

  SAC2052398
• Published Date :

  May 1, 2022
• Number of Pages :

  350.0

The Epithelial Stem Cells market was valued at US$ xx in 2021, prior to COVID-19. Whereas post-COVID-19 scenario, the market for Epithelial Stem Cells is projected to grow from US$ xx million in 2021, and is proje…

• SKU :

  SAC2052372
• Published Date :

  May 1, 2022
• Number of Pages :

  350.0

The Tauopathies Treatment market was valued at US$ xx in 2021, prior to COVID-19. Whereas post-COVID-19 scenario, the market for Tauopathies Treatment is projected to grow from US$ xx million in 2021, and is proje…

• SKU :

  SAC2052351
• Published Date :

  May 1, 2022
• Number of Pages :

  350.0

The Non-Tyrosine Kinase Inhibitors market was valued at US$ xx in 2021, prior to COVID-19. Whereas post-COVID-19 scenario, the market for Non-Tyrosine Kinase Inhibitors is projected to grow from US$ xx million in …

• SKU :

  SAC2052348
• Published Date :

  May 1, 2022
• Number of Pages :

  350.0

The Medical Writing market was valued at US$ xx in 2021, prior to COVID-19. Whereas post-COVID-19 scenario, the market for Medical Writing is projected to grow from US$ xx million in 2021, and is projected to reac…

• SKU :

  SAC2052304
• Published Date :

  May 1, 2022
• Number of Pages :

  350.0

The Marine Bone Collagen Peptide Powder market was valued at US$ xx in 2021, prior to COVID-19. Whereas post-COVID-19 scenario, the market for Marine Bone Collagen Peptide Powder is projected to grow from US$ xx m…

• SKU :

  SAC2052295
• Published Date :

  May 1, 2022
• Number of Pages :

  350.0

The Glipizide (CAS 29094-61-9) market was valued at US$ xx in 2021, prior to COVID-19. Whereas post-COVID-19 scenario, the market for Glipizide (CAS 29094-61-9) is projected to grow from US$ xx million in 2021, an…

• SKU :

  SAC2052257
• Published Date :

  May 1, 2022
• Number of Pages :

  350.0

The Pulmonary Arterial Hypertension (PAH) Drugs market was valued at US$ xx in 2021, prior to COVID-19. Whereas post-COVID-19 scenario, the market for Pulmonary Arterial Hypertension (PAH) Drugs is projected to gr…

• SKU :

  SAC2052256
• Published Date :

  May 1, 2022
• Number of Pages :

  350.0

The Integrin Alpha 4 market was valued at US$ xx in 2021, prior to COVID-19. Whereas post-COVID-19 scenario, the market for Integrin Alpha 4 is projected to grow from US$ xx million in 2021, and is projected to re…

• SKU :

  SAC2052236
• Published Date :

  May 1, 2022
• Number of Pages :

  350.0